Victory Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.61M | Sell |
99,364
-39,321
| -28% | -$1.76M | ﹤0.01% | 1433 |
|
|
2025
Q4 | $6.46M | Sell |
138,685
-94,701
| -41% | -$4.22M | ﹤0.01% | 1218 |
|
|
2025
Q3 | $9.72M | Sell |
233,386
-28,145
| -11% | -$900K | 0.01% | 1117 |
|
|
2025
Q2 | $7.52M | Buy |
261,531
+10,200
| +4% | +$315K | ﹤0.01% | 1193 |
|
|
2025
Q1 | $8.43M | Sell |
251,331
-30,120
| -11% | -$1.12M | 0.01% | 1115 |
|
|
2024
Q4 | $14.4M | Sell |
281,451
-61,893
| -18% | -$3.46M | 0.01% | 955 |
|
|
2024
Q3 | $17.5M | Buy |
343,344
+116,657
| +51% | +$6.02M | 0.02% | 895 |
|
|
2024
Q2 | $10.2M | Sell |
226,687
-30,458
| -12% | -$1.41M | 0.01% | 1073 |
|
|
2024
Q1 | $12M | Buy |
257,145
+73,038
| +40% | +$2.86M | 0.01% | 1006 |
|
|
2023
Q4 | $6.55M | Buy |
184,107
+139,117
| +309% | +$4.27M | 0.01% | 1187 |
|
|
2023
Q3 | $1.34M | Buy |
+44,990
| New | +$927K | ﹤0.01% | 1519 |
|
|
2023
Q1 | – | Sell |
-66,428
| Closed | -$1.22M | – | 2611 |
|
|
2022
Q4 | $1.22M | Sell |
66,428
-32,640
| -33% | -$575K | ﹤0.01% | 1632 |
|
|
2022
Q3 | $1.95M | Sell |
99,068
-11,210
| -10% | -$229K | ﹤0.01% | 1462 |
|
|
2022
Q2 | $2.06M | Hold |
110,278
| – | – | ﹤0.01% | 1447 |
|
|
2022
Q1 | $2.42M | Sell |
110,278
-4,490
| -4% | -$90.9K | ﹤0.01% | 1439 |
|
|
2021
Q4 | $3.26M | Sell |
114,768
-80,670
| -41% | -$1.99M | ﹤0.01% | 1417 |
|
|
2021
Q3 | $4.11M | Buy |
195,438
+115,820
| +145% | +$2.42M | ﹤0.01% | 1381 |
|
|
2021
Q2 | $1.5M | Sell |
79,618
-3,540
| -4% | -$62.2K | ﹤0.01% | 1720 |
|
|
2021
Q1 | $1.27M | Buy |
83,158
+30,720
| +59% | +$476K | ﹤0.01% | 1802 |
|
|
2020
Q4 | $740K | Sell |
52,438
-9,240
| -15% | -$129K | ﹤0.01% | 1906 |
|
|
2020
Q3 | $966K | Sell |
61,678
-2,080
| -3% | -$31.8K | ﹤0.01% | 1718 |
|
|
2020
Q2 | $1.12M | Sell |
63,758
-305,690
| -83% | -$5.21M | ﹤0.01% | 1680 |
|
|
2020
Q1 | $5.43M | Buy |
369,448
+174,210
| +89% | +$3.57M | ﹤0.01% | 1250 |
|
|
2019
Q4 | $4.9M | Sell |
195,238
-19,130
| -9% | -$364K | 0.01% | 1193 |
|
|
2019
Q3 | $3.22M | Buy |
214,368
+144,698
| +208% | +$2.81M | ﹤0.01% | 1301 |
|
|
2019
Q2 | $1.74M | Buy |
69,670
+16,300
| +31% | +$404K | ﹤0.01% | 1176 |
|
|
2019
Q1 | $1.22M | Sell |
53,370
-590
| -1% | -$14.5K | ﹤0.01% | 1210 |
|
|
2018
Q4 | $1.62M | Sell |
53,960
-40,850
| -43% | -$1.15M | ﹤0.01% | 1093 |
|
|
2018
Q3 | $2.72M | Buy |
+94,810
| New | +$2.81M | 0.01% | 1036 |
|
Other funds holding CRNX
FCM
DCM
VCM
VPM
EC